|
|
|
|
|
|
|
By Rachel Grabenhofer, Chief Editor, Clinical Supply Leader
|
This second installment of our Root Causes video series explores how protocol assumptions can create downstream operational and clinical supply challenges.
|
|
|
|
|
|
|
|
By Tom Walls, Axon Bridge Consulting
|
Clinical-stage companies have no sales history, but they still have demand. Here’s how to uncover the four streams driving supply planning before material gets tight.
|
|
|
|
|
|
|
|
By Laura Hay, Trax Group
|
Clinical trials are too unpredictable for inventory strategies built on fixed assumptions. Learn why agility, visibility and smarter buffers are becoming essential to supply planning.
|
|
|
|
|
|
|
|
|
|
Demand-Led Clinical Supply For Global Product Pooling
|
|
Case Study | Catalent
|
See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
